Ronald de Vries - Concepedia

Author

Ronald de Vries

Janssen (Belgium)ORCID

Also Known As

R de Vries, R. de Vries, Reinier de Vries, Ronald De Vries, Ronald de Vries, Vries, Ronald

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Janssen (United States)GlaxoSmithKline (United Kingdom)Hirosaki University QPS (Netherlands)

About

Ronald de Vries is an author at Janssen (Belgium) specializing in medicine, pharmacology, and bioanalysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	805
2	Biochemistry	5	5	133
3	Engineering	3	3	144
4	Health Sciences	1	1	36
5	Natural Sciences	1	1	15

Ronald de Vries

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study Anas Younes, Catherine Thiéblemont, Franck Morschhauser, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyImmune Checkpoint Inhibitor	2014	250
A Device for Dried Blood Microsampling in Quantitative Bioanalysis: Overcoming The Issues Associated Blood Hematocrit Neil Spooner, Philip Denniff, L. Michielsen, Bioanalysis	2014	216
The Effect of Hematocrit on Bioanalysis of DBS: Results from The EBF DBS-Microsampling Consortium Ronald de Vries, Matthew Barfield, Nico van de Merbel, Bioanalysis	2013	129
Update of The EBF Recommendation for The Use of DBS in Regulated Bioanalysis Integrating The Conclusions from The EBF DBS-Microsampling Consortium Philip Timmerman, Steve White, Zoe Cobb, Bioanalysis EngineeringBiomolecular ToolDbs TechnologyBiomedical EngineeringEuropean Bioanalysis Forum	2013	110
Effect of <scp>CYP</scp>3A perpetrators on ibrutinib exposure in healthy participants Jan de Jong, Donna Skee, Joe Murphy, Pharmacology Research & Perspectives	2015	98
Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography–tandem mass spectrometry Bart Remmerie, Luc Sips, Ronald de Vries, Journal of Chromatography B MedicineBioanalysisMass SpectrometryHuman PlasmaAnalytical Chemistry	2002	87
Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults Ronald de Vries, Johan W. Smit, Peter Hellemans, British Journal of Clinical Pharmacology	2015	70
Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes Shingo Ono, Kazuo Mihara, Akihito Suzuki, Psychopharmacology Cyp2d6 GenotypesPharmacologyPharmacogenomicsPharmacotherapySignificant Pharmacokinetic Interaction	2002	66
In-Depth Study of Homogeneity in DBS Using Two Different Techniques: Results from The EBF DBS-Microsampling Consortium Zoe Cobb, Ronald de Vries, Neil Spooner, Bioanalysis	2013	64
Effects of various factors on steady‐state plasma concentrations of risperidone and 9‐hydroxyrisperidone: lack of impact of MDR‐1 genotypes Norio Yasui‐Furukori, Kazuo Mihara, Takenori Takahata, British Journal of Clinical Pharmacology	2004	59

Page 1